Victory Capital Management
NVAX icon

Victory Capital Management’s Novavax NVAX Stock Holding History

Victory Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$148K Sell
18,138
-9,117
-33% -$82.6K ﹤0.01% 2236
2025
Q4 		$183K Sell
27,255
-17,177
-39% -$129K ﹤0.01% 2216
2025
Q3 		$385K Sell
44,432
-555
-1% -$4.32K ﹤0.01% 2100
2025
Q2 		$283K Buy
44,987
+27,289
+154% +$181K ﹤0.01% 2173
2025
Q1 		$113K Sell
17,698
-1,230
-6% -$10.2K ﹤0.01% 2299
2024
Q4 		$152K Sell
18,928
-364
-2% -$3.51K ﹤0.01% 2279
2024
Q3 		$244K Buy
19,292
+2,072
+12% +$26.8K ﹤0.01% 2178
2024
Q2 		$218K Sell
17,220
-128
-0.7% -$1.29K ﹤0.01% 2182
2024
Q1 		$82.9K Buy
17,348
+2,257
+15% +$10.5K ﹤0.01% 2322
2023
Q4 		$72.4K Buy
+15,091
New +$92.4K ﹤0.01% 2390
2022
Q3 		– Sell
-10,319
Closed -$531K – 2749
2022
Q2 		$531K Sell
10,319
-7,415
-42% -$384K ﹤0.01% 2028
2022
Q1 		$799K Sell
17,734
-16,505
-48% -$1.47M ﹤0.01% 1920
2021
Q4 		$4.9M Sell
34,239
-919
-3% -$158K ﹤0.01% 1331
2021
Q3 		$7.29M Sell
35,158
-26,167
-43% -$5.77M 0.01% 1198
2021
Q2 		$13M Buy
61,325
+10,799
+21% +$1.98M 0.01% 1045
2021
Q1 		$9.16M Buy
50,526
+29,970
+146% +$5.97M 0.01% 1166
2020
Q4 		$2.29M Buy
20,556
+2,638
+15% +$280K ﹤0.01% 1477
2020
Q3 		$1.94M Sell
17,918
-13,715
-43% -$1.67M ﹤0.01% 1453
2020
Q2 		$2.64M Buy
31,633
+14,523
+85% +$555K ﹤0.01% 1349
2020
Q1 		$232K Buy
+17,110
New +$145K ﹤0.01% 2296
2019
Q4 		– Sell
-3,973
Closed -$20K – 3043
2019
Q3 		$20K Buy
+3,973
New +$21.7K ﹤0.01% 3044
2016
Q3 		– Sell
-195
Closed -$28K – 1815
2016
Q2 		$28K Buy
195
+8
+4% +$917 ﹤0.01% 1580
2016
Q1 		$19K Buy
187
+14
+8% +$1.5K ﹤0.01% 1614
2015
Q4 		$29K Buy
173
+10
+6% +$1.54K ﹤0.01% 1622
2015
Q3 		$23K Buy
163
+12
+8% +$2.69K ﹤0.01% 1578
2015
Q2 		$34K Buy
+151
New +$26.5K ﹤0.01% 1563

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management's NVAX Position: Q1 2026 in Review

Victory Capital Management reduced its Novavax (NVAX) stake by 33% in Q1 2026, selling an estimated $82.6K and leaving 18,138 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #2236.

Victory Capital Management first reported a position in NVAX in Q2 2015 and has held it in 26 quarters since. The position peaked at $13M in Q2 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Victory Capital Management held 18,138 shares of Novavax worth $148K as of Q1 2026.
  • Victory Capital Management sold 9,117 Novavax shares in Q1 2026, an estimated $82.6K.
  • Novavax made up ﹤0.01% of Victory Capital Management's portfolio in Q1 2026, its #2236 holding.
  • Victory Capital Management first reported a position in Novavax in Q2 2015 and has held it in 26 quarters since.
  • Victory Capital Management's Novavax position peaked at $13M in Q2 2021.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.